Together, these data indicate that SLC39A6 overexpression was a significant independent prognostic factor for poor prognosis in ESCC and could thus be used as a potential biomarker for prognosis evaluation in patients with ESCC. Here, SLC39A6 is linked to esophageal squamous cell carcinoma.